Study Spotlight: Rochester 3 Needs Toddlers, Minovacca's Neuro Focus, & Key Research Updates - #S10e159 Tuesday, January 28, 2025 - Week 5 STUDIES OF THE WEEK - ROCHESTER 3 We need 3 more 0-2 Year olds. curesyngap1.org/resources/studies/neurodevelopmental-disorders-health-index-study-rochester-phase-3 NYU - CureSYNGAP1.org/NYU curesyngap1.org/resources/studies/accuracy-of-smart-phone-identification-of-seizures-and-non-seizure-events-in-rare-genetic-epilepsies-nyu-langone-health Tracker page: docs.google.com/spreadsheets/d/1oQLNi85AUbISmcW0KbsgGn4cBK_4MNuvwGlKUUKLyIQ/edit?usp=sharing STUDY HUDDLE on THURSDAY! 1/30 noon ET - register cureSYNGAP1.org/StudyHuddle; main emphasis Rochester, Frazier, NYU COMPANY OF THE WEEK - Minovacca SRF put Neuro on their radar and now they are building a company. news.unl.edu/article/nebraska-based-startup-aims-to-improve-human-health-through-targeted-drug-delivery Press releases for Zempleni: curesynga...